Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01310205
What this trial is testing

Extension Study SCI-SCV-HCV-P2-001: Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Completing Treatment in HCV

Who this might be right for
Chronic Hepatitis C
SciClone Pharmaceuticals 12
Post-approval studies (Phase 4)Study completedNCT02461745
What this trial is testing

Real World Study: Genotype 1 Chronic Hepatitis C Virus Treatment and Evaluation of Real World SVR and PRO

Who this might be right for
Hepatitis C, Chronic
Kaiser Permanente 200
Testing effectiveness (Phase 2)Study completedNCT02336139
What this trial is testing

A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use

Who this might be right for
Hepatitis C
Kirby Institute 103
Large-scale testing (Phase 3)Study completedNCT00299936
What this trial is testing

Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve Subjects

Who this might be right for
Chronic Hepatitis C
Weill Medical College of Cornell University 5,000
Not applicableStudy completedNCT00725205
What this trial is testing

Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 294
Early research (Phase 1)Study completedNCT01448200
What this trial is testing

PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1

Who this might be right for
Hepatitis C, Chronic
Presidio Pharmaceuticals, Inc. 82
Not applicableStudy completedNCT04214028
What this trial is testing

The Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 50
Large-scale testing (Phase 3)UnknownNCT01623336
What this trial is testing

BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 740
Large-scale testing (Phase 3)Study completedNCT00623428
What this trial is testing

Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 235
Not applicableStudy completedNCT05669677
What this trial is testing

Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease

Who this might be right for
Chronic or Recovered Hepatitis BChronic or Recovered Hepatitis CChronic or Recovered Hepatitis D+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 233
Not applicableWithdrawnNCT01813266
What this trial is testing

Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors

Who this might be right for
Chronic Hepatitis C Virus Infection
Intermountain Health Care, Inc.
Early research (Phase 1)WithdrawnNCT00449124
What this trial is testing

TG4040 in Patients With Chronic HCV

Who this might be right for
Hepatitis C
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT03490097
What this trial is testing

Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination

Who this might be right for
Chronic Hepatitis cMetabolic Syndrome
Ain Shams University 100
Not applicableStudy completedNCT02557646
What this trial is testing

An Observational Study to Assess the Effect of Cumulative Ribavirin Dose in Participants With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 697
Post-approval studies (Phase 4)Study completedNCT02972723
What this trial is testing

Metformin Therapy in HCV Infection

Who this might be right for
Chronic Hepatitis C Infection
Nottingham University Hospitals NHS Trust 16
Large-scale testing (Phase 3)Study completedNCT02105662
What this trial is testing

An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus in Participants Who Are Co-Infected With Human Immunodeficiency Virus:C-EDGE CO-INFXN (MK-5172-061)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 218
Not applicableUnknownNCT05170490
What this trial is testing

Long Term Follow up of Chronic HCV Patients Receiving DAAS

Who this might be right for
Chronic Hepatitis c
Sohag University 100
Large-scale testing (Phase 3)Study completedNCT00048724
What this trial is testing

Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)

Who this might be right for
Chronic Hepatitis CCirrhosis
Merck Sharp & Dohme LLC 631
Early research (Phase 1)Study completedNCT01889849
What this trial is testing

Comparative Pharmacokinetics and Pharmacodynamics of Peginterferon BIP48 and 40kDa in Healthy Volunteers

Who this might be right for
Chronic Viral Hepatitis C
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 32
Post-approval studies (Phase 4)Study completedNCT03781726
What this trial is testing

Multi-center Study to Transplant Hepatitis-C Infected Kidneys

Who this might be right for
Renal Failure ChronicHepatitis C
Raymond Chung 30
Next Page